Identification of inflammation markers as novel potential predictors of the HIV-DNA reservoir size

The dynamics of the HIV reservoir during antiretroviral therapy (ART) exhibit variability, with a pronounced decline during the initial years of treatment. However, the identification of biomarkers and host factors associated with the decay of the different forms of HIV proviruses remains to be full...

Descripción completa

Detalles Bibliográficos
Autores: Torre Tarazona, Humberto Erick de la, Moraga López, Elisa, Fons Contreras, María, Vaquer Tomé, Raúl, Sánchez-Palomino, Sonsoles, Vallejo Palma, Germán, Calderón Vicente, Sergio, Vicens Artés, Sònia, Llois Aldámiz-Echevarría, Maria T., Ciudad Sañudo, Marianela, Moreno, Cristina, Armenteros Yeguas, Inés, Tiraboschi, Juan Manuel, Reus Bañuls, Sergio, Alcamí, José, Serrano Villar, Sergio, Moreno, Santiago, CoRIS cohort
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2025
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/223516
Acceso en línea:https://hdl.handle.net/2445/223516
Access Level:acceso abierto
Palabra clave:VIH (Virus)
Marcadors bioquímics
Virologia molecular
HIV (Viruses)
Biochemical markers
Molecular virology
Descripción
Sumario:The dynamics of the HIV reservoir during antiretroviral therapy (ART) exhibit variability, with a pronounced decline during the initial years of treatment. However, the identification of biomarkers and host factors associated with the decay of the different forms of HIV proviruses remains to be fully elucidated. We conducted a longitudinal study on people with HIV provided by the Spanish National HIV cohort. We assessed the HIV-DNA levels by Intact Proviral DNA Assay, and inflammatory markers using the Proximity Extension Assay, before and after ART initiation. A multivariate linear regression model was employed to identify potential predictive markers. Our results highlight the identification of novel inflammatory markers, such as ADA, DNER, CDCP1, SCF, among others, that varied significantly over ART initiation. In addition, we observed several markers associated with intact HIV-DNA before ART initiation (CD8A, CX3CL1, and ST1A1) or during undetectable viral load post-ART (IL-10). Moreover, up to five markers were able to predict the intact HIV reservoir decay over ART. The strongest predictor was Stem Cell Factor (SCF), where higher baseline levels of this marker were associated with a greater decline in the intact HIV reservoir. In conclusion, we have identified inflammatory markers associated with the size and dynamics of the HIV-DNA reservoir. These findings provide new insights that could contribute to the development of multi-targeted intervention strategies aimed at modulating or monitoring the HIV reservoir size.